McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Richard H. Carmona, M.D. DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: James H. Hinton DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025 AUDIT-RELATED ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Advisory vote on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Approve Amendment to Certificate of Incorporation to Provide for Officer Exculpation CORPORATE GOVERNANCE ISSUER 95200.000000 0 FOR 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Shareholder Proposal on Independent Board Chairman CORPORATE GOVERNANCE SECURITY HOLDER 95200.000000 0 AGAINST 95200.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Shareholder Proposal on Report on Risks of State Policies Restricting Reproductive Health Care OTHER SOCIAL ISSUES SECURITY HOLDER 95200.000000 0 AGAINST 95200.000000 FOR S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to set the number of directors of the Company at five (5) CORPORATE GOVERNANCE ISSUER 49896829.000000 0 FOR 49896829.000000 FOR S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to elect the nominees proposed by Management in the management information circular of the Company dated September 6, 2024 (the "Circular") as directors of the Company for the ensuing year: David Daily DIRECTOR ELECTIONS ISSUER 49896829.000000 0 WITHHOLD 49896829.000000 AGAINST S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to elect the nominees proposed by Management in the management information circular of the Company dated September 6, 2024 (the "Circular") as directors of the Company for the ensuing year: Leonid Gontmakher DIRECTOR ELECTIONS ISSUER 49896829.000000 0 WITHHOLD 49896829.000000 AGAINST S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to elect the nominees proposed by Management in the management information circular of the Company dated September 6, 2024 (the "Circular") as directors of the Company for the ensuing year: Chetan Gulati DIRECTOR ELECTIONS ISSUER 49896829.000000 0 WITHHOLD 49896829.000000 AGAINST S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to elect the nominees proposed by Management in the management information circular of the Company dated September 6, 2024 (the "Circular") as directors of the Company for the ensuing year: Kristopher Krane DIRECTOR ELECTIONS ISSUER 49896829.000000 0 WITHHOLD 49896829.000000 AGAINST S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to elect the nominees proposed by Management in the management information circular of the Company dated September 6, 2024 (the "Circular") as directors of the Company for the ensuing year: Roman Tkachenko DIRECTOR ELECTIONS ISSUER 49896829.000000 0 WITHHOLD 49896829.000000 AGAINST S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to appoint Davidson & Company LLP as auditor of the Company for the ensuing year and to authorize the directors to fix their remuneration AUDIT-RELATED ISSUER 49896829.000000 0 FOR 49896829.000000 FOR S000005666 4Front Ventures Corp. 35086B207 CA35086B2075 10/18/2024 to consider, and if thought fit, to pass, with or without variation, an ordinary resolution ratifying, confirming and approving the Company's restricted equity plan (the "Restricted Equity Plan") and the grant of up to 100,000,000 restricted share units or restricted stock agreements under the Restricted Equity Plan COMPENSATION ISSUER 49896829.000000 0 AGAINST 49896829.000000 AGAINST S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Ratify Ernst & Young LLP as Auditors AUDIT-RELATED ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Elect Director Ye Wang DIRECTOR ELECTIONS ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Elect Director Darren Xiaohui Ji DIRECTOR ELECTIONS ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Elect Director Ying Huang DIRECTOR ELECTIONS ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Elect Director Tomas Heyman DIRECTOR ELECTIONS ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Amend Restricted Stock Plan COMPENSATION ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 10/21/2024 Authorize Board to Ratify and Execute Approved Resolutions CORPORATE GOVERNANCE ISSUER 234286.000000 0 FOR 234286.000000 FOR S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Non-Financial Report CORPORATE GOVERNANCE ENVIRONMENT OR CLIMATE HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Allocation of Income and Dividends of CHF 3.50 per Share CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve CHF 38 Million Reduction in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Authorize Repurchase of up to CHF 10 Billion in Issued Share Capital CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Virtual-Only Shareholder Meetings CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Remuneration of Directors in the Amount of CHF 8.2 Million COMPENSATION ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Remuneration of Executive Committee in the Amount of CHF 95 Million COMPENSATION ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Approve Remuneration Report COMPENSATION ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Elect Giovanni Caforio as Director and Board Chair DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Nancy Andrews as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Ton Buechner as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Patrice Bula as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Elizabeth Doherty as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Bridgette Heller as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Daniel Hochstrasser as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Frans van Houten as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Simon Moroney as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect Ana de Pro Gonzalo as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reelect John Young as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Elect Elizabeth McNally as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reappoint Patrice Bula as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reappoint Bridgette Heller as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Reappoint Simon Moroney as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Appoint John Young as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Ratify KPMG AG as Auditors AUDIT-RELATED ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Designate Peter Zahn as Independent Proxy CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/07/2025 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Approve Allocation of Income and Dividends of DKK 7.9 Per Share CAPITAL STRUCTURE ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Approve Remuneration of Directors for 2024 COMPENSATION ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Approve Remuneration Level of Directors for 2025 COMPENSATION ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Helge Lund (Chair) as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Henrik Poulsen (Vice Chair) as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Laurence Debroux as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Andreas Fibig as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Sylvie Gregoire as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Kasim Kutay as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Christina Law as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Reelect Martin Mackay as Director DIRECTOR ELECTIONS ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Ratify Deloitte as Auditors; Ratify Deloitte as Auditors for Sustainability Reporting AUDIT-RELATED ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Approve Creation of DKK 44.7 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 44.7 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 44.7 Million CAPITAL STRUCTURE ISSUER 966242.000000 0 FOR 966242.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/27/2025 Approve Proposal Regarding Regulated Working Conditions at Construction Sites HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 966242.000000 0 AGAINST 966242.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Alf Gunnar Martin Nicklasson as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Kirsten Aarup Drejer as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Jeffrey Berkowitz as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Leonard Kruimer as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Bernadette Mary Connaughton as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Elaine Sullivan as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Reelect Enrique Conterno as Director DIRECTOR ELECTIONS ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Ratify Pricewaterhouse Coopers as Auditors; Ratify Pricewaterhouse Coopers as Auditors for Sustainability Reporting AUDIT-RELATED ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 92662.000000 0 AGAINST 92662.000000 AGAINST S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Approve Remuneration of Directors in the Amount of DKK 100,000 for Each Director, and 5,000 RSU for Chair, 1,000 RSU for Vice Chair and 1,500 RSU for Other Directors; Approve Remuneration for Committee Work in RSUs COMPENSATION ISSUER 92662.000000 0 AGAINST 92662.000000 AGAINST S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Approve Creation of DKK 7.1 Million Pool of Capital without Preemptive Rights CAPITAL STRUCTURE ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Approve Creation of DKK 14.2 Million Pool of Capital with Preemptive Rights CAPITAL STRUCTURE ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 Zealand Pharma A/S K9898X127 DK0060257814 03/27/2025 Approve Issuance of Warrants without Preemptive Rights up to Aggregate Nominal Amount of DKK 220,000 CAPITAL STRUCTURE ISSUER 92662.000000 0 FOR 92662.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Approve Dividends CAPITAL STRUCTURE ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Reappoint PricewaterhouseCoopers LLP as Auditors AUDIT-RELATED ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise Board to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Michel Demare as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Pascal Soriot as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Aradhana Sarin as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Philip Broadley as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Euan Ashley as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Elect Birgit Conix as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Elect Rene Haas as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Elect Karen Knudsen as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Diana Layfield as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Anna Manz as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Sheri McCoy as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Tony Mok as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Nazneen Rahman as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Re-elect Marcus Wallenberg as Director DIRECTOR ELECTIONS ISSUER 576205.000000 0 AGAINST 576205.000000 AGAINST S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Approve Remuneration Report COMPENSATION ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise UK Political Donations and Expenditure OTHER SOCIAL ISSUES ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 576205.000000 0 FOR 576205.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/11/2025 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 576205.000000 0 AGAINST 576205.000000 AGAINST S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: John W. Garratt DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 Humana Inc. 444859102 US4448591028 04/17/2025 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 59100.000000 0 FOR 59100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Retired Maj. Gen. Elder Granger, M.D. DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 32100.000000 0 FOR 32100.000000 FOR S000005666 The Cigna Group 125523100 US1255231003 04/23/2025 Shareholder proposal - Support Special Shareholder Meeting Improvement CORPORATE GOVERNANCE SECURITY HOLDER 32100.000000 0 AGAINST 32100.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Darius Adamczyk DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 564643.000000 0 FOR 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Shareholder opportunity to vote on excessive golden parachutes COMPENSATION SECURITY HOLDER 564643.000000 0 AGAINST 564643.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/24/2025 Produce a human rights impact assessment HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 564643.000000 0 AGAINST 564643.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To re-elect Kenneth Cunningham, M.D. as a director of the Company. DIRECTOR ELECTIONS ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To re-elect Vikas Sinha as a director of the Company. DIRECTOR ELECTIONS ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To re-elect James Brady as a director of the Company. DIRECTOR ELECTIONS ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To receive and adopt the U.K. statutory annual accounts and Directors' report for the year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended December 31, 2024. COMPENSATION ISSUER 173700.000000 0 AGAINST 173700.000000 AGAINST S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To re-appoint Ernst & Young LLP as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders. AUDIT-RELATED ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To authorize the Audit and Risk Committee to determine the auditors' remuneration for the year ending December 31, 2025. AUDIT-RELATED ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 173700.000000 0 AGAINST 173700.000000 AGAINST S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds7,031,895 (being up to a maximum of 140,637,892 shares representing 20% of the Company's existing ordinary share capital as at the close of business on March 11, 2025 (being the latest practicable date prior to publication of this document)). CAPITAL STRUCTURE ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Verona Pharma Plc 925050106 US9250501064 04/24/2025 To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561(1) of the Companies Act does not apply to any such allotment. CAPITAL STRUCTURE ISSUER 173700.000000 0 FOR 173700.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: R. J. Alpern DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/25/2025 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 434000.000000 0 FOR 434000.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Allocation of Income and Dividends of EUR 3.92 per Share CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Transaction with l'Oreal Re: Share Repurchase Agreement CORPORATE GOVERNANCE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Ratify Appointment of Jean-Paul Kress as Director DIRECTOR ELECTIONS ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Reelect Carole Ferrand as Director DIRECTOR ELECTIONS ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Reelect Barbara Lavernos as Director DIRECTOR ELECTIONS ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Reelect Emile Voest as Director DIRECTOR ELECTIONS ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Reelect Antoine Yver as Director DIRECTOR ELECTIONS ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Compensation of Frederic Oudea, Chairman of the Board COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Compensation of Paul Hudson, CEO COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Remuneration Policy of Directors COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Remuneration Policy of CEO COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Decrease in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights (Rights Issue) up to Aggregate Nominal Amount of EUR 997 Million CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 240 Million CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 240 Million CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Approve Issuance of Debt Securities Giving Access to New Shares of Subsidiaries and/or Debt Securities, up to Aggregate Amount of EUR 7 Billion CAPITAL STRUCTURE OTHER ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 18, 19, and 20 CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Capitalization of Reserves of Up to EUR 500 Million for Bonus Issue or Increase in Par Value CAPITAL STRUCTURE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries COMPENSATION ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Amend Articles 3 and 13 of Bylaws CORPORATE GOVERNANCE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/30/2025 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 345661.000000 0 FOR 345661.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Yoshiaki Fujimori DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: John E. Sununu DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 725048.000000 0 FOR 725048.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Stockholder proposal titled "Support Simple Majority Vote." CORPORATE GOVERNANCE SECURITY HOLDER 725048.000000 0 FOR 725048.000000 NONE S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Amal M. Johnson DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 131300.000000 0 FOR 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The stockholder proposal purportedly "to improve the executive compensation program," if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 131300.000000 0 AGAINST 131300.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The stockholder proposal that is titled "requesting a shareholder approval requirement for excessive golden parachutes," if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 131300.000000 0 FOR 131300.000000 AGAINST S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Ralph Alvarez DIRECTOR ELECTIONS ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Kimberly Johnson DIRECTOR ELECTIONS ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Juan Luciano DIRECTOR ELECTIONS ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2025. AUDIT-RELATED ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 237200.000000 0 FOR 237200.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Carolyn R. Bertozzi, Ph.D. DIRECTOR ELECTIONS ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Margaret A. Hamburg, M.D. DIRECTOR ELECTIONS ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Colleen F. Reitan DIRECTOR ELECTIONS ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To elect the following nominees as Class III directors of Alnylam: Amy W. Schulman DIRECTOR ELECTIONS ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To approve an Amendment to our Restated Certificate of Incorporation allowing for officer exculpation. CORPORATE GOVERNANCE ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To approve the second amended and restated 2018 Stock Incentive Plan. COMPENSATION ISSUER 77700.000000 0 AGAINST 77700.000000 AGAINST S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/08/2025 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 77700.000000 0 FOR 77700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: William H.L. Burnside DIRECTOR ELECTIONS ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Thomas C. Freyman DIRECTOR ELECTIONS ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Brett J. Hart DIRECTOR ELECTIONS ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Edward J. Rapp DIRECTOR ELECTIONS ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 520700.000000 0 FOR 520700.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Stockholder Proposal - to Implement Simple Majority Vote CORPORATE GOVERNANCE SECURITY HOLDER 520700.000000 0 FOR 520700.000000 AGAINST S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 36600.000000 0 FOR 36600.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/14/2025 Shareholder proposal, if properly presented at the meeting, regarding excessive golden parachutes. COMPENSATION SECURITY HOLDER 36600.000000 0 FOR 36600.000000 AGAINST S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Roger N. Farah DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED ISSUER 267600.000000 0 FOR 267600.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 267600.000000 0 AGAINST 267600.000000 AGAINST S000005666 CVS Health Corporation 126650100 US1266501006 05/15/2025 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 267600.000000 0 AGAINST 267600.000000 FOR S000005666 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Nominees: Matthew K. Fust DIRECTOR ELECTIONS ISSUER 194000.000000 0 FOR 194000.000000 FOR S000005666 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Nominees: Amrit Ray, M.D. DIRECTOR ELECTIONS ISSUER 194000.000000 0 FOR 194000.000000 FOR S000005666 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Approval of the Second Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 194000.000000 0 AGAINST 194000.000000 AGAINST S000005666 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 194000.000000 0 FOR 194000.000000 FOR S000005666 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/15/2025 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 194000.000000 0 FOR 194000.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Elect five directors to serve until the 2026 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Innoviva, Inc. 45781M101 US45781M1018 05/19/2025 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 3335650.000000 0 FOR 3335650.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: James C. Mullen DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 127600.000000 0 ABSTAIN 127600.000000 AGAINST S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2025. AUDIT-RELATED ISSUER 127600.000000 0 FOR 127600.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Shareholder proposal. CORPORATE GOVERNANCE SECURITY HOLDER 127600.000000 0 AGAINST 127600.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Approve Remuneration Report COMPENSATION ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Approve Allocation of Income to the Retained Earnings of the Company CAPITAL STRUCTURE ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Approve Remuneration Policy COMPENSATION ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Reelect Anthony Rosenberg as Non-Executive Director DIRECTOR ELECTIONS ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/27/2025 Grant Board Authority to Issue Shares and Exclude Pre-emptive Rights CAPITAL STRUCTURE ISSUER 38299.000000 0 FOR 38299.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Elect Lars Luthjohan as Chair of Meeting CORPORATE GOVERNANCE ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Albert Cha as Director DIRECTOR ELECTIONS ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Lars Holtug as Director DIRECTOR ELECTIONS ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Jan Moller Mikkelsen as Director DIRECTOR ELECTIONS ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Lisa Jane Morrison as Director DIRECTOR ELECTIONS ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect William Carl Fairey Jr as Director DIRECTOR ELECTIONS ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Siham Imani as Director DIRECTOR ELECTIONS ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Ratify Deloitte as Auditor AUDIT-RELATED ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Approve Creation of DKK 3.8 Million Pool of Capital without Preemptive Rights CAPITAL STRUCTURE ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Approve Issuance of Warrants to Board Members COMPENSATION ISSUER 317388.000000 0 AGAINST 317388.000000 AGAINST S000005666 Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Amend Articles Re: Board-Related CORPORATE GOVERNANCE ISSUER 317388.000000 0 FOR 317388.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Ratification of the appointment of the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 253371.000000 0 FOR 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a human rights impact assessment. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 253371.000000 0 AGAINST 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a tax transparency report. OTHER SOCIAL ISSUES SECURITY HOLDER 253371.000000 0 AGAINST 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal to revisit DEl goals in executive pay incentives. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 253371.000000 0 AGAINST 253371.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a report on civil liberties in advertising services. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 253371.000000 0 AGAINST 253371.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Michele Hooper DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 277800.000000 0 FOR 277800.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 If properly presented at the 2025 Annual Meeting of Shareholders, the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. COMPENSATION SECURITY HOLDER 277800.000000 0 AGAINST 277800.000000 FOR S000005666 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Jorge Santos da Silva DIRECTOR ELECTIONS ISSUER 174800.000000 0 FOR 174800.000000 FOR S000005666 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Simon Sturge DIRECTOR ELECTIONS ISSUER 174800.000000 0 FOR 174800.000000 FOR S000005666 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Election of the three Class III director nominees to serve until the 2028 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Andrew Phillips DIRECTOR ELECTIONS ISSUER 174800.000000 0 FOR 174800.000000 FOR S000005666 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 174800.000000 0 FOR 174800.000000 FOR S000005666 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/05/2025 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 174800.000000 0 FOR 174800.000000 FOR S000005666 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Ronald Barrett, Ph.D. DIRECTOR ELECTIONS ISSUER 198985.000000 0 FOR 198985.000000 FOR S000005666 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: David Campbell, Ph.D. DIRECTOR ELECTIONS ISSUER 198985.000000 0 FOR 198985.000000 FOR S000005666 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Winston Kung DIRECTOR ELECTIONS ISSUER 198985.000000 0 FOR 198985.000000 FOR S000005666 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 198985.000000 0 FOR 198985.000000 FOR S000005666 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 198985.000000 0 FOR 198985.000000 FOR S000005666 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2025 Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 198985.000000 0 ONE YEAR 198985.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 06/12/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 93161.000000 141125.000000 FOR 93161.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 06/12/2025 Ratify Ernst & Young LLP as Auditors AUDIT-RELATED ISSUER 93161.000000 141125.000000 FOR 93161.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 06/12/2025 Elect Director Patrick Casey DIRECTOR ELECTIONS ISSUER 93161.000000 141125.000000 FOR 93161.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 06/12/2025 Elect Director Yau Wai Man Philip DIRECTOR ELECTIONS ISSUER 93161.000000 141125.000000 FOR 93161.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 06/12/2025 Elect Director Fangliang Zhang DIRECTOR ELECTIONS ISSUER 93161.000000 141125.000000 FOR 93161.000000 FOR S000005666 Legend Biotech Corporation 52490G102 US52490G1022 06/12/2025 Authorize Board to Ratify and Execute Approved Resolutions CORPORATE GOVERNANCE ISSUER 93161.000000 141125.000000 FOR 93161.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Bonnie L. Bassler, Ph.D. DIRECTOR ELECTIONS ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Michael S. Brown, M.D. DIRECTOR ELECTIONS ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Leonard S. Schleifer, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: George D. Yancopoulos, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation CORPORATE GOVERNANCE ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article VI of the Certificate of Incorporation. CORPORATE GOVERNANCE ISSUER 47500.000000 0 FOR 47500.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Elisabeth Bjork, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 925300.000000 0 WITHHOLD 925300.000000 AGAINST S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 925300.000000 0 WITHHOLD 925300.000000 AGAINST S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Pedro Granadillo DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gotham Makker, M.D. DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Piratip Pratumsuwan DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. Southwell DIRECTOR ELECTIONS ISSUER 925300.000000 0 WITHHOLD 925300.000000 AGAINST S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 06/18/2025 Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 925300.000000 0 FOR 925300.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Approve Allocation of Income, with a Final Dividend of JPY 30 CAPITAL STRUCTURE ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Manabe, Sunao DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Okuzawa, Hiroyuki DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Matsumoto, Takashi DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Komatsu, Yasuhiro DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Nishii, Takaaki DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Homma, Yo DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Joseph Kenneth Keller DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Ueno, Shizuko DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Watanabe, Akihiro DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Kinoshita, Reiko DIRECTOR ELECTIONS ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Appoint Statutory Auditor Yokoyama, Terumichi COMPENSATION CORPORATE GOVERNANCE ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Appoint Statutory Auditor Watanabe, Masako COMPENSATION CORPORATE GOVERNANCE ISSUER 421100.000000 0 FOR 421100.000000 FOR S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Election of the Class II directors, each to serve for a three year term until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jennifer Good DIRECTOR ELECTIONS ISSUER 66200.000000 0 WITHHOLD 66200.000000 AGAINST S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Election of the Class II directors, each to serve for a three year term until the 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 66200.000000 0 WITHHOLD 66200.000000 AGAINST S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 66200.000000 0 FOR 66200.000000 FOR S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 66200.000000 0 AGAINST 66200.000000 AGAINST S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Approval of an amendment to our Amended and Restated Certificate of Incorporation to provide for exculpation of officers from breaches of fiduciary duty to the fullest extent permitted by the General Corporation Law of the State of Delaware (the "Officer Exculpation Proposal"). CORPORATE GOVERNANCE ISSUER 66200.000000 0 FOR 66200.000000 FOR S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2025 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve the Officer Exculpation Amendment. CORPORATE GOVERNANCE ISSUER 66200.000000 0 FOR 66200.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Approve Allocation of Income, with a Final Dividend of JPY 13 CAPITAL STRUCTURE ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Takagi, Toshiaki DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Samejima, Hikaru DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Osada, Toshihiko DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Kunimoto, Norimasa DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Nishi, Hidenori DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Ozawa, Keiya DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Kogiso, Mari DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director and Audit Committee Member Shibazaki, Takanori DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director and Audit Committee Member Uno, Soichiro DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director and Audit Committee Member Hayashi, Keiko DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Alternate Director and Audit Committee Member Kosugi, Hiroaki DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666 Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Alternate Director and Audit Committee Member Shirato, Asako DIRECTOR ELECTIONS ISSUER 283800.000000 0 FOR 283800.000000 FOR S000005666